Technical Analysis for ALPN - Alpine Immune Sciences, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | -2.50% | |
Volume Surge | Other | -2.50% | |
Wide Bands | Range Expansion | -3.11% | |
Wide Bands | Range Expansion | -2.69% | |
Gapped Up | Strength | -2.69% | |
Wide Bands | Range Expansion | 0.25% | |
Down 3 Days in a Row | Weakness | 0.25% | |
MACD Bearish Signal Line Cross | Bearish | -1.28% | |
Slingshot Bullish | Bullish Swing Setup | -1.28% |
Alert | Time |
---|---|
20 DMA Support | about 11 hours ago |
10 DMA Resistance | about 11 hours ago |
Down 3% | about 11 hours ago |
Fell Below 20 DMA | about 11 hours ago |
Fell Below Previous Day's Low | about 11 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/21/2024
Alpine Immune Sciences, Inc., a development-stage specialty pharmaceutical company, engages in the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders, and other diseases. It is developing ALPN-101, an ICOS/CD28 antagonist program for the treatment of inflammatory diseases. The company is based in Seattle, Washington.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Pharmaceutical Disease Immune System Immunotherapy Medication Treatment Of Cancer Immunotherapies Inflammatory Diseases Stage Specialty Pharmaceutical Inflammatory Disorders Treatment Of Inflammatory Disease Treatment Of Inflammatory Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Pharmaceutical Disease Immune System Immunotherapy Medication Treatment Of Cancer Immunotherapies Inflammatory Diseases Stage Specialty Pharmaceutical Inflammatory Disorders Treatment Of Inflammatory Disease Treatment Of Inflammatory Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 39.27 |
52 Week Low | 6.395 |
Average Volume | 1,143,148 |
200-Day Moving Average | 16.82 |
50-Day Moving Average | 28.59 |
20-Day Moving Average | 35.33 |
10-Day Moving Average | 36.51 |
Average True Range | 1.78 |
RSI (14) | 59.02 |
ADX | 48.55 |
+DI | 23.54 |
-DI | 15.49 |
Chandelier Exit (Long, 3 ATRs) | 33.94 |
Chandelier Exit (Short, 3 ATRs) | 34.64 |
Upper Bollinger Bands | 39.33 |
Lower Bollinger Band | 31.33 |
Percent B (%b) | 0.52 |
BandWidth | 22.66 |
MACD Line | 2.13 |
MACD Signal Line | 2.63 |
MACD Histogram | -0.5026 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 38.16 | ||||
Resistance 3 (R3) | 38.31 | 37.55 | 37.71 | ||
Resistance 2 (R2) | 37.55 | 36.86 | 37.48 | 37.56 | |
Resistance 1 (R1) | 36.51 | 36.44 | 36.13 | 36.37 | 37.41 |
Pivot Point | 35.76 | 35.76 | 35.57 | 35.68 | 35.76 |
Support 1 (S1) | 34.72 | 35.07 | 34.34 | 34.57 | 33.53 |
Support 2 (S2) | 33.96 | 34.65 | 33.89 | 33.38 | |
Support 3 (S3) | 32.92 | 33.96 | 33.23 | ||
Support 4 (S4) | 32.78 |